Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 20303354)

1.

Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.

Huo X, Zhang HY, Zhang XI, Lynch JP, Strauch ED, Wang JY, Melton SD, Genta RM, Wang DH, Spechler SJ, Souza RF.

Gastroenterology. 2010 Jul;139(1):194-203.e1. doi: 10.1053/j.gastro.2010.03.035. Epub 2010 Mar 17.

2.

Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.

Zhang HY, Zhang X, Chen X, Thomas D, Hormi-Carver K, Elder F, Spechler SJ, Souza RF.

Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G470-8. doi: 10.1152/ajpgi.90262.2008. Epub 2008 Jul 10.

3.

Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.

Feagins LA, Zhang HY, Zhang X, Hormi-Carver K, Thomas T, Terada LS, Spechler SJ, Souza RF.

Am J Physiol Gastrointest Liver Physiol. 2008 Feb;294(2):G411-7. Epub 2007 Dec 6.

4.

Bile acids directly augment caudal related homeobox gene Cdx2 expression in oesophageal keratinocytes in Barrett's epithelium.

Kazumori H, Ishihara S, Rumi MA, Kadowaki Y, Kinoshita Y.

Gut. 2006 Jan;55(1):16-25. Epub 2005 Aug 23.

5.

Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development.

Kazumori H, Ishihara S, Kinoshita Y.

Gut. 2009 May;58(5):620-8. doi: 10.1136/gut.2008.152975. Epub 2009 Jan 9.

PMID:
19136512
6.

The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells.

Hu Y, Williams VA, Gellersen O, Jones C, Watson TJ, Peters JH.

J Gastrointest Surg. 2007 Jul;11(7):827-34. Erratum in: J Gastrointest Surg. 2008 Feb;12(2):400.

PMID:
17458588
7.

Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells.

Debruyne PR, Witek M, Gong L, Birbe R, Chervoneva I, Jin T, Domon-Cell C, Palazzo JP, Freund JN, Li P, Pitari GM, Schulz S, Waldman SA.

Gastroenterology. 2006 Apr;130(4):1191-206.

PMID:
16618413
8.

Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.

Am J Gastroenterol. 2005 Jun;100(6):1257-64.

PMID:
15929754
9.

Ectopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett's esophagus.

Kong J, Crissey MA, Funakoshi S, Kreindler JL, Lynch JP.

PLoS One. 2011 Apr 6;6(4):e18280. doi: 10.1371/journal.pone.0018280.

10.

Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR.

Surgery. 2005 Nov;138(5):924-31.

PMID:
16291394
11.

Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.

Eda A, Osawa H, Satoh K, Yanaka I, Kihira K, Ishino Y, Mutoh H, Sugano K.

J Gastroenterol. 2003;38(1):14-22.

PMID:
12560917
12.

Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway.

Hormi-Carver K, Zhang X, Zhang HY, Whitehead RH, Terada LS, Spechler SJ, Souza RF.

Cancer Res. 2009 Jan 15;69(2):672-7. doi: 10.1158/0008-5472.CAN-08-3703.

13.

Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.

Tamagawa Y, Ishimura N, Uno G, Yuki T, Kazumori H, Ishihara S, Amano Y, Kinoshita Y.

Lab Invest. 2012 Jun;92(6):896-909. doi: 10.1038/labinvest.2012.56. Epub 2012 Mar 26.

14.

In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.

Peng S, Huo X, Rezaei D, Zhang Q, Zhang X, Yu C, Asanuma K, Cheng E, Pham TH, Wang DH, Chen M, Souza RF, Spechler SJ.

Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15;307(2):G129-39. doi: 10.1152/ajpgi.00085.2014. Epub 2014 May 22.

PMID:
24852569
15.

Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.

Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A, Corcoran-Schwartz IM, Wilburn DL, Montgomery EA, Wang JS, Jenkins NA, Copeland NA, Harmon JW, Phillips WA, Watkins DN.

Gastroenterology. 2010 May;138(5):1810-22. doi: 10.1053/j.gastro.2010.01.048. Epub 2010 Feb 4.

16.

Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.

Souza RF, Shewmake KL, Shen Y, Ramirez RD, Bullock JS, Hladik CL, Lee EL, Terada LS, Spechler SJ.

Am J Gastroenterol. 2005 Mar;100(3):551-9.

PMID:
15743351
17.

NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy.

Abdel-Latif MM, O'Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D, Reynolds JV.

Ann Surg. 2004 Apr;239(4):491-500.

18.

Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.

Yen CJ, Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, Hung MC.

Cancer Res. 2008 Apr 15;68(8):2632-40. doi: 10.1158/0008-5472.CAN-07-5460.

19.

Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.

Stairs DB, Nakagawa H, Klein-Szanto A, Mitchell SD, Silberg DG, Tobias JW, Lynch JP, Rustgi AK.

PLoS One. 2008;3(10):e3534. doi: 10.1371/journal.pone.0003534. Epub 2008 Oct 27.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk